Stay updated on Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest updates to the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check32 days agoNo Change Detected
- Check47 days agoChange DetectedThe website has been updated to version 2.10.0, adding new features including additional conditions, interventions, and study numbers, along with information about 6 study locations.SummaryDifference0.8%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check60 days agoChange DetectedDifference0.2%
- Check65 days agoChange DetectedDifference0.2%
Stay in the know with updates to Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.